Anika buys Biopolymer unit of Fidia Farmaceutici
This article was originally published in Scrip
Executive Summary
Anika Therapeutics has acquired Fidia Advanced Biopolymers (FAB), a wholly owned subsidiary of Fidia Farmaceutici, in a cash and stock deal. US-based Anika will pay $17.1 million in cash and hand over nearly 2 million shares for the privately held Italian firm.